Transcriptome analysis reveals the difference between \"healthy\" and \"common\" aging and their connection with age-related diseases

A key goal of aging research is to understand mechanisms underlying healthy aging and use them to develop methods to promote the human healthspan. One approach is to identify gene regulations differentiating healthy aging from aging in the general population (i.e., \"common\" aging). In this study, we leveraged GTEx (Genotype-Tissue Expression) project data to investigate \"healthy\" and \"common\" aging in humans and their interconnection with diseases.\n\nWe selected GTEx donors who were not annotated with diseases to approximate a \"healthy\" aging cohort. We then compared the age-associated genes derived from this cohort with age-associated genes from our \"common\" aging cohort which included all GTEx donors; we also compared the \"healthy\" and \"common\" aging gene expressions with various disease-associated gene expression to elucidate the relationships among \"healthy\", \"common\" aging and disease. Our analyses showed that 1. \"healthy\" and \"common\" aging shared a large number of gene regulations; 2. Despite the substantial commonality, \"healthy\" and \"common\" aging genes also showed distinct function enrichment, and \"common\" aging genes had a higher enrichment for disease genes; 3. Disease-associated gene regulations were overall different from aging gene regulations. However, for genes regulated by both, their regulation directions were largely consistent, implying some aging processes could increase the susceptibility to disease development; and 4. Possible protective mechanisms were associated with the \"healthy\" aging gene regulations.\n\nIn summary, our work highlights several unique features of human \"healthy\" aging program. This new knowledge can be used for the development of therapeutics to promote human healthspan.